CAPSAICIN for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 7 adverse event reports in the FDA FAERS database where CAPSAICIN was used for Psoriasis.
Most Reported Side Effects for CAPSAICIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Application site pain | 401 | 23.3% | 0 | 33 |
| Drug ineffective | 279 | 16.2% | 2 | 94 |
| Pain | 237 | 13.8% | 4 | 20 |
| Burning sensation | 209 | 12.2% | 1 | 17 |
| Application site erythema | 112 | 6.5% | 0 | 14 |
| Fatigue | 91 | 5.3% | 0 | 76 |
| Off label use | 91 | 5.3% | 1 | 26 |
| Pain in extremity | 89 | 5.2% | 0 | 10 |
| Weight increased | 80 | 4.7% | 0 | 47 |
| Insomnia | 72 | 4.2% | 1 | 54 |
| Application site burn | 67 | 3.9% | 0 | 8 |
| Poor quality sleep | 65 | 3.8% | 0 | 63 |
| Erythema | 63 | 3.7% | 1 | 13 |
| Impaired work ability | 60 | 3.5% | 0 | 56 |
| Herpes zoster | 58 | 3.4% | 0 | 48 |
Other Indications for CAPSAICIN
Diabetic neuropathy (491)
Product used for unknown indication (307)
Neuralgia (264)
Complex regional pain syndrome (132)
Neuropathy peripheral (80)
Pain (71)
Post herpetic neuralgia (71)
Arthralgia (25)
Back pain (18)
Procedural pain (14)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)